Expanded Production of Novel COVID-19 Reference Materials Announced
Mar 24 2020 Read 946 Times
With the rapid global spread of the SARS-CoV-2 virus and the urgent need for reliable diagnostic solutions, LGC’s SeraCare Life Sciences is expanding production of their novel COVID-19 reference materials to include high titre stocks that serve as a valuable tool for diagnostic manufacturers.
Michael Sweatt, Executive Vice President and General Manager, LGC Diagnostics BU, stated: “As a leading provider to the in vitro diagnostic industry, we are keenly aware of the important role that reliable reference materials play in the development of accurate diagnostic tests. Offering our AccuPlex COVID-19 solution in a high titre format enables diagnostic manufacturers to accelerate development efforts through use of concentrated, lot-specific reference material to complete their assay validation activities. Our dedicated team of scientists are expediting production of these stocks, and we anticipate availability in the coming week.”
AccuPlex reference materials, while mimicking wild-type pathogenic viruses, are safe, non-infectious, and replication-deficient. They serve as true, full-process, quality control solutions that challenge the entire diagnostic workflow, making them a valuable alternative to infectious materials.
More information online
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles - Export experts talk Corona Virus - Automated cell counting shouldn’t cost the earth Laboratory Products - Spectrophotometer Linearity Validation - Analysi...
View all digital editions
May 31 2020 Houston, TX, USA
May 31 2020 Baltimore, MD, USA
Jun 11 2020 Brussels, Belgium
Jun 20 2020 San Diego, CA, USA
Jun 30 2020 Nuremberg, Germany